🏆 Featured in Datapile’s Q2 2026 USA Funding Report
Read the Q2 2026 USA report →Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile’s Q2 2026 USA Funding Report</a>Funding history
- 1
Founder
G
Gregory Verdine
CEO
Investors in Parabilis Medicines
Backers from this company's tracked funding rounds.
- RRegeneron PharmaceuticalsLead investorVC firm
Parabilis Medicines in the news
Coverage of this company's funding, tracked by Datapile.
- Parabilis sets a record with a $670M biotech IPO ↗BioPharma Dive · Jun 10, 2026Also covered byqz.com
More Health companies
Recently funded startups in the same category.